Back
Neurogene Stock Predictions
Sponsored
NGNE
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
75
NGNE
Neurogene
Last Price:
65.96
Seasonality Move:
58.98%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeNeurogene Stock Forecast
- Over the next 52 weeks, Neurogene has on average historically risen by 60.7% based on the past 10 years of stock performance.
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Neurogene Stock Undervalued?
The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal. - NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Neurogene Stock Go Up Next Year?
- Over the next 52 weeks, Neurogene has on average historically risen by 60.7% based on the past 10 years of stock performance.
Neurogene Stock Rating
Buy
75
Neurogene (NGNE)
is a Buy
Is Neurogene overpriced?
- Neurogene has risen higher in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Neurogene Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurogene.com
52-Week Data
52-Week High:
73.59
52-Week Low:
12.49
Prediction Charts
Market Cap:
857.58M
Price in USD:
66.00
Volume:
960.71K
Beta:
-1.26
Technical Analysis
SMA50:
43.32
SMA100:
40.68
SMA200:
37.93
52-Wk Change:
382.46%
Stock Predictions
-
Is Neurogene stock public?
Yes, Neurogene is a publicly traded company. -
What is the Neurogene stock quote today?
The Neurogene stock price is 66.00 USD today. -
How to buy Neurogene stock online?
You can buy Neurogene shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-15 | 49.85 | 50.05 | 50.75 | 47.49 |
Oct-16 | 50.53 | 53.26 | 54.38 | 50.53 |
Oct-18 | 53.21 | 54.40 | 55.21 | 53.11 |
Oct-21 | 54.64 | 52.66 | 54.64 | 52.30 |
Oct-22 | 52.59 | 49.97 | 52.68 | 48.00 |
Oct-23 | 49.97 | 48.55 | 51.42 | 48.15 |
Oct-24 | 48.69 | 48.20 | 49.38 | 47.67 |
Oct-25 | 48.45 | 48.37 | 50.85 | 47.76 |
Oct-28 | 49.14 | 45.93 | 51.19 | 45.80 |
Oct-29 | 45.40 | 45.27 | 46.94 | 44.49 |
Oct-30 | 45.08 | 43.58 | 46.01 | 43.58 |
Oct-31 | 43.56 | 44.01 | 44.31 | 42.23 |
Nov-1 | 44.73 | 46.07 | 46.23 | 44.47 |
Nov-4 | 56.17 | 66.00 | 73.59 | 55.00 |
Neurogene Earnings
Neurogene Earnings Report: Per Share Neurogene Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurogene Forecast Revenue Growth
Neurogene Stock Analysis: Historical quarterly revenues per share for Neurogene and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.
* Neurogene stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.